PERMIT final meeting: so long, not goodbye
June 21, 2022

On June 16th and 17th the PERMIT project consortium, personalised medicine experts and other invested stakeholders met in Milan (and online) at the Istituto di Recherche Farmacologiche Mario Negri to discuss the recommendations that were developed over the 2.5 years of the project.

Read more
Implementation workshop
March 17, 2022

On 17 March, the PERMIT project held its Implementation Workshop. This workshop aimed to gather key stakeholders of the personalised medicine research pipeline, to discuss how to best disseminate and implement the PERMIT recommendations.

Read more
3rd PERMIT General Assembly
July 21, 2021

On 7 July, the PERMIT consortium met for its third General Assembly, to go over the achievements conducted over the past 6 months, and to discuss the activities for the next semester. In total nine different working sessions, focus groups and stakeholder consultations were held between February and July within work packages 3 to 6. 

Read more
Regulatory gaps in the personalised medicine pipeline
July 15, 2021

On 12 July, the PERMIT project held an online working session to discuss the regulatory gaps in the personalised medicine research pipeline. Gathering over 30 participants from within and beyond the PERMIT consortium, the session focused on the gaps and questions identified through the scoping reviews and consultation exercises. 

Read more
Study designs for clinical trials applied to personalised medicine
July 12, 2021

In July, PERMIT WP6 hosted two working sessions mainly focused on three specific trial designs commonly used in the field of personalised medicine (platform, umbrella and basket design). Experts in the field discussed how these three complex trial designs can be used for the development of personalised medicine, their advantages, and their disadvantages. 

Read more